Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference76 articles.
1. The significance of Survivin and Nectin-4 expression in the prognosis of breast carcinoma;Athanassiadou;Folia Histochem Cytobiol.,2011
2. Sacituzumab govitecan in metastatic triple-negative breast cancer;Bardia;N. Engl. J. Med.,2021
3. Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer;Bardia;Ann. Oncol.,2021
4. Cleavable linkers in antibody-drug conjugates;Bargh;Chem. Soc. Rev.,2019
5. Abstract OT-03-03: SGNLVA-001: a phase 1 open-label dose escalation and expansion study of SGN-LIV1A administered weekly in breast cancer;Beckwith;Cancer Res.,2021
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antibody-drug conjugates targeting DDR1 as a novel strategy for treatment of breast cancer;Journal of Drug Targeting;2024-08-09
2. Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies;MedComm;2024-07-28
3. Efficacy and safety of antibody–drug conjugates in the treatment of urothelial cell carcinoma: a systematic review and meta-analysis of prospective clinical trials;Frontiers in Pharmacology;2024-06-12
4. Computer-aided drug discovery strategies for novel therapeutics for prostate cancer leveraging next-generating sequencing data;Expert Opinion on Drug Discovery;2024-06-11
5. Bispecific antibody drug conjugates: Making 1+1>2;Acta Pharmaceutica Sinica B;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3